STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Lexicon Pharmaceuticals to Participate in Two Upcoming December Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Lexicon Pharmaceuticals (Nasdaq: LXRX) said management will participate in two investor conferences in early December 2025: a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025 at 9:00 AM ET and a presentation at the Evercore 8th Annual Healthcare Conference on Thursday, December 4, 2025 at 9:10 AM ET.

Live events and replays will be available on the company’s Events page at https://investors.lexpharma.com/.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

THE WOODLANDS, Texas, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3 at 9:00 a.m. ET and at the 8th Annual Evercore Healthcare Conference on Thursday, December 4 at 9:10 a.m. ET.

The live events and replays of the presentations can be accessed via the Events page of the Company’s website at https://investors.lexpharma.com/.

About Lexicon Pharmaceuticals 
Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Through the Genome5000™ program, Lexicon’s unique genomics target discovery platform, Lexicon scientists studied the role and function of nearly 5,000 genes and identified more than 100 protein targets with significant therapeutic potential in a range of diseases. Through the precise targeting of these proteins, Lexicon is pioneering the discovery and development of innovative medicines to safely and effectively treat disease. Lexicon has advanced multiple medicines to market and has a pipeline of promising drug candidates in discovery and clinical and preclinical development in heart failure, neuropathic pain, obesity, cardiology, diabetes and other indications. For additional information, please visit www.lexpharma.com

For Investor and Media Inquiries
Lisa DeFrancesco  
Lexicon Pharmaceuticals, Inc. 
lexinvest@lexpharma.com


FAQ

When will Lexicon Pharmaceuticals (LXRX) present at the Piper Sandler healthcare conference?

Lexicon will present on Wednesday, December 3, 2025 at 9:00 AM ET at the Piper Sandler 37th Annual Healthcare Conference.

What time is Lexicon Pharmaceuticals (LXRX) scheduled at the Evercore healthcare conference?

Lexicon is scheduled for Thursday, December 4, 2025 at 9:10 AM ET at the Evercore 8th Annual Healthcare Conference.

Where can investors watch Lexicon (LXRX) conference presentations and replays?

Live events and replays are available on Lexicon’s Events page: https://investors.lexpharma.com/.

Will Lexicon (LXRX) host a fireside chat at the Piper Sandler conference?

Yes, company management will participate in a fireside chat at the Piper Sandler conference on December 3, 2025.

Are the Lexicon (LXRX) conference dates confirmed for December 2025?

Yes, the announced dates are December 3, 2025 and December 4, 2025, with times listed for each session.
Lexicon Pharmaceuticals Inc

NASDAQ:LXRX

LXRX Rankings

LXRX Latest News

LXRX Latest SEC Filings

LXRX Stock Data

486.95M
358.94M
1.17%
72.07%
7.94%
Biotechnology
Pharmaceutical Preparations
Link
United States
THE WOODLANDS